New flavored chemo drink aims to ease treatment for kids with hard-to-treat cancers
NCT ID NCT04337177
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 37 times
Summary
This early-phase study tests a flavored, drinkable version of the chemotherapy drug irinotecan (VAL-413) combined with another drug (temozolomide) in children and young adults up to age 30 whose solid tumors have come back. The main goal is to find the safest dose and see how the body processes the medicine. About 20 participants will take the drugs for five days in a row, and researchers will monitor side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Atrium Health Levine Children's Hospital - Carolinas Medical Center
Charlotte, North Carolina, 28204, United States
-
Children's Healthcare of Atlanta - Arthur M. Blank Hospital
Atlanta, Georgia, 30329, United States
-
Children's National Research Institute - Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Duke University Children's Hospital and Health Center
Durham, North Carolina, 27710, United States
-
Indiana University School of Medicine, Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
Sarah Cannon Research Institute, Pediatric Hematology & Oncology
Nashville, Tennessee, 37203, United States
-
UCSF, Mission Bay - Benioff Children's Hospital
San Francisco, California, 94143, United States
-
University of North Carolina at Chapel Hill - North Carolina Cancer Hospital
Chapel Hill, North Carolina, 27514, United States
-
Washington University - St. Louis
St Louis, Missouri, 63110, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.